To further investigate whether TRIM26 inhibited cell malignant behaviors depending on ETK-mediated inactivation of mTOR signaling pathway, we altered the expression levels of ETK and TRIM26 in ccRCC cells at the same time and examined their impact on malignant behavior. This evidence concerns the gene MTOR and nonpapillary renal cell carcinoma.